Search for: "Smith v. Flynn" Results 1 - 20 of 76
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jun 2023, 9:00 pm by Michael C. Dorf
Congress did just that in the Ethics in Government Act, but SCOTUS upheld the independent counsel in Morrison v. [read post]
23 Sep 2022, 4:00 am by Jim Sedor
Spending in election cycles by corporations and the ultrawealthy through so-called dark money groups has skyrocketed since the 2010 Supreme Court decision Citizens United v. [read post]
21 Jan 2022, 3:00 am by Jim Sedor
Now with Senate Allies, Spanberger’s Legislation to Ban Members of Congress from Trading Stock Gains Traction MSN – Meagan Flynn (Washington Post) | Published: 1/17/2022 More than a year since U.S. [read post]
13 May 2021, 11:44 pm
Ebenezer Scrooge and Marley's GhostJane LambertPatents Court (Mr Justice Matcus Smith) Neurim Pharmaceuticals (1991) Ltd and Another v Generics UK Ltd (t/a Mylan) and another  [2021] EWHC 530 (Pat) (12 March 2021)This was an action by Neurim Pharmaceuticals (1991) Ltd ("Neurim") the proprietor of European patent (UK) 1 441 702 B1  and Flynn Pharma Ltd ("Flynn"), its purported exclusive licensee, [read post]
7 Apr 2021, 12:23 pm by Adam Faderewski
• Thomas Flynn, 49, of Richardson, died July 17, 2020. [read post]
  This follows his 4 December 2020 judgment in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited [2020] EWHC 3270 (Pat) (the “Judgment”). [read post]
20 Dec 2020, 8:43 am by Anna Salvatore, Tia Sewell
Smith proposed four ways in which President-elect Biden could make progress on cybersecurity on day one. [read post]
On 4 December 2020, the English Patents Court handed down its decision in Neurim Pharmaceuticals (1991) Limited & Flynn Pharma Limited v Generics UK Limited (t/a Mylan) & Mylan UK Healthcare Limited, the main action proceedings regarding Neurim’s patent for Circadin, EP 1 441 702 (“EP 702”). [read post]
1 Jul 2020, 4:32 pm
Jane Lambert Court of Appeal (Lords Justices Floyd, Males and Arnold) Neurim Pharmaceuticals (1991) Ltd and another v Generics UK Ltd (t/a Mylan) and another [2020] EWCA Civ 793 (24 June 2020) This was an appeal by the claimants, Neurim Pharmaceuticals (1991) Ltd ("Neurim") and its exclusive licensee Flynn Pharma Ltd ("Flynn"), against Mr Justice Marcus Smith's refusal in Neurim [read post]